Transforming HCV Management

by Graham Foster, Patrick Marcellin, Ira Jacobson, Heiner Wedemeyer, Christophe Hézode, Antonio Craxì
Published 2014-05-01

Welcome to the Real World: Hepatitis C Virus Clinical Trials to Patient Realities

by Heiner Wedemeyer, Ira Jacobson, Heiner Wedemeyer, Robert S. Brown, Jr., Antonio Craxí, Ira Jacobson
Published 2016-05-01

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey

by Maria Cappello, Claudia Randazzo, Ivana Bravatà, Anna Licata, Sergio Peralta, Antonio Craxì, Piero Luigi Almasio
Published 2014-07-01

Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey

by Maria Cappello, Claudia Randazzo, Ivana Bravatà, Anna Licata, Sergio Peralta, Antonio Craxì, Piero Luigi Almasio
Published 2014-06-01

Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases.

by Salvatore Petta, Fabio Salvatore Macaluso, Maria Rosa Barcellona, Calogero Cammà, Daniela Cabibi, Vito Di Marco, Antonio Craxì
Published 2012-01-01

Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.

by Salvatore Petta, Alessandro Ciresi, Jessica Bianco, Vincenzo Geraci, Roberta Boemi, Luigi Galvano, Franco Magliozzo, Giovanni Merlino, Antonio Craxì, Carla Giordano
Published 2017-01-01

Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression

by Loreta A. Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Antonio Saverio Roscini, Rocco Merolla, Walter Marrocco, Antonio Craxì
Published 2021-03-01

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.

by Serena Pelusi, Salvatore Petta, Chiara Rosso, Vittorio Borroni, Anna Ludovica Fracanzani, Paola Dongiovanni, Antonio Craxi, Elisabetta Bugianesi, Silvia Fargion, Luca Valenti
Published 2016-01-01

Progression-Free Survival Early Assessment is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma

by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Anita Busacca, Domenica Matranga, Massimo Attanasio, Maria Reig, Antonio Craxì, Calogero Cammà
Published 2021-12-01

Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis

by Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Stefania Grimaudo, Domenica Matranga, Massimo Attanasio, Paolo Bruzzi, Antonio Craxì, Calogero Cammà
Published 2020-07-01

SARS-CoV-2 Viral Load, IFNλ Polymorphisms and the Course of COVID-19: An Observational Study

by Emanuele Amodio, Rosaria Maria Pipitone, Stefania Grimaudo, Palmira Immordino, Carmelo Massimo Maida, Tullio Prestileo, Vincenzo Restivo, Fabio Tramuto, Francesco Vitale, Antonio Craxì, Alessandra Casuccio
Published 2020-10-01

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.

by Anna Licata, Salvatore Corrao, Salvatore Petta, Chiara Genco, Mauro Cardillo, Vincenza Calvaruso, Giuseppe Cabibbo, Giuseppe Cabibbo, Fatima Massenti, Calogero Cammà, Giuseppe Licata, Antonio Craxì
Published 2013-01-01

PNPLA3 and TLL-1 Polymorphisms as Potential Predictors of Disease Severity in Patients With COVID-19

by Stefania Grimaudo, Emanuele Amodio, Rosaria Maria Pipitone, Carmelo Massimo Maida, Stefano Pizzo, Tullio Prestileo, Fabio Tramuto, Davide Sardina, Francesco Vitale, Alessandra Casuccio, Antonio Craxì
Published 2021-06-01

Performance of two HCV RNA assays during protease inhibitor-based triple therapy in patients with advanced liver fibrosis and cirrhosis.

by Benjamin Maasoumy, Bela Hunyady, Vincenza Calvaruso, Mihály Makara, Johannes Vermehren, Attila Haragh, Simone Susser, Birgit Bremer, Gavin Cloherty, Michael P Manns, Antonio Craxì, Heiner Wedemeyer, Christoph Sarrazin
Published 2014-01-01

Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease.

by Salvatore Petta, Luca Miele, Elisabetta Bugianesi, Calogero Cammà, Chiara Rosso, Stefania Boccia, Daniela Cabibi, Vito Di Marco, Stefania Grimaudo, Antonio Grieco, Rosaria Maria Pipitone, Giulio Marchesini, Antonio Craxì
Published 2014-01-01

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).

by Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R Foster, Antonio Craxí, Peter Buggisch, Robert Ryan, Oliver Lenz, Jane Scott, Gino Van Dooren, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti
Published 2016-01-01

Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.

by Salvatore Petta, Oreste Marrone, Daniele Torres, Maria Buttacavoli, Calogero Cammà, Vito Di Marco, Anna Licata, Anna Lo Bue, Gaspare Parrinello, Antonio Pinto, Adriana Salvaggio, Antonino Tuttolomondo, Antonio Craxì, Maria Rosaria Bonsignore
Published 2015-01-01

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate...

by Tarik Asselah, Christophe Moreno, Christoph Sarrazin, Michael Gschwantler, Graham R Foster, Antonio Craxí, Peter Buggisch, Faisal Sanai, Ceyhun Bicer, Oliver Lenz, Gino Van Dooren, Catherine Nalpas, Isabelle Lonjon-Domanec, Michael Schlag, Maria Buti
Published 2017-01-01

Survival of patients with hepatocellular carcinoma (HCC) treated by percutaneous radio-frequency ablation (RFA) is affected by complete radiological response.

by Giuseppe Cabibbo, Giuseppe Cabibbo, Marcello Maida, Chiara Genco, Nicola Alessi, Marco Peralta, Giuseppe Butera, Massimo Galia, Giuseppe Brancatelli, Claudio Genova, Maurizio Raineri, Emanuele Orlando, Simona Attardo, Antonino Giarratano, Massimo Midiri, Vito Di Marco, Antonio Craxì, Calogero Cammà
Published 2013-01-01

PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.

by Salvatore Petta, Luca Valenti, Giulio Marchesini, Vito Di Marco, Anna Licata, Calogero Cammà, Maria Rosa Barcellona, Daniela Cabibi, Benedetta Donati, Anna Fracanzani, Stefania Grimaudo, Gaspare Parrinello, Rosaria Maria Pipitone, Daniele Torres, Silvia Fargion, Giuseppe Licata, Antonio Craxì
Published 2013-01-01